B6;SJL-Tg(aP2-SREBF1c)9884Reh/J

B6;SJL-Tg(aP2-SREBF1c)9884Reh/J

Cat. No.: DMM-001252

Status Age Sex
  • Live Mouse
  • Frozen Embryo
  • 4 weeks
  • 12 weeks
  • Customized Age
  • Male
  • Female
Model Overview
Model Description This transgenic mouse model recapitulates human congenital generalized lipodystrophy (CGL) through adipose tissue-specific overexpression of SREBP-1c, which leads to the core characteristics of CGL: a near absence of adipose tissue, severe insulin resistance, and consequent type II diabetes and fatty liver.
Strain Name B6;SJL-Tg(aP2-SREBF1c)9884Reh/J
Background Strain (C57BL/6J x SJL)F2
SPF Yes
Research Application Diabetes
Target Information
Target Name transgene insertion 9884
Synonyms aP2-SREBP-1c436
Gene ID -
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Models
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top